A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
Clinical trial NCT02072213 · COMPLETED
Trial details
- NCT number
- NCT02072213
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.